LQDA Liquidia Corporation
Stock · NasdaqCM · United States · Healthcare · US53635D2027
NowoTrade is an independent information site. It is not affiliated with, endorsed by or sponsored by Liquidia Corporation, and has no access to any account you may have with it. The name and the logo belong to their owners.
Price
44.40 USD
-0.20%
52-week range
22.31 – 93.61
Dividend yield—
Market cap4.0B
NowoTrade score
50 Grade A
Price history
Daily prices in USD.
Updated 08 Nov 2026 14:27. Information, not advice.
Results
Next results
10 Nov 2026
in 2 days · 08:00 · estimate 0.98
Last results
0.74 vs 0.85 estimated
12 Aug 2026 · Miss -13.2%
Beat the estimate
3 of 12
9 missed · 0 in line
Average surprise
-12.4%
reported against the estimate, last 12 quarters
Earnings per share: estimate and reported
Estimate Reported: beat Reported: miss In line
Quarterly results
| Date | EPS estimate | EPS reported | Surprise | Result |
|---|---|---|---|---|
| 10 Nov 2026 08:00 | 0.98 | — | — | Upcoming |
| 12 Aug 2026 06:00 | 0.85 | 0.74 | -13.2% | Miss |
| 11 May 2026 06:00 | 0.40 | 0.52 | +29.2% | Beat |
| 05 Mar 2026 06:00 | 0.33 | 0.15 | -55.1% | Miss |
| 03 Nov 2025 06:00 | -0.35 | -0.04 | +88.7% | Beat |
| 12 Aug 2025 06:00 | -0.39 | -0.49 | -24.8% | Miss |
| 08 May 2025 06:00 | -0.42 | -0.45 | -7.1% | Miss |
| 19 Mar 2025 06:00 | -0.39 | -0.45 | -13.9% | Miss |
| 13 Nov 2024 06:00 | -0.40 | -0.39 | +2.2% | Beat |
| 07 Aug 2024 07:00 | -0.33 | -0.37 | -12.1% | Miss |
| 13 May 2024 17:00 | -0.28 | -0.39 | -37.0% | Miss |
| 13 Mar 2024 07:00 | -0.23 | -0.42 | -78.7% | Miss |
| 07 Nov 2023 06:00 | -0.19 | -0.24 | -26.3% | Miss |
| 10 Aug 2023 06:00 | -0.16 | -0.36 | -125.0% | Miss |
| 04 May 2023 16:00 | -0.17 | -0.15 | +16.6% | Beat |
| 16 Mar 2023 06:00 | -0.17 | -0.09 | +46.0% | Beat |
| 08 Nov 2022 16:00 | -0.19 | -0.14 | +26.3% | Beat |
| 11 Aug 2022 16:00 | -0.22 | -0.15 | +31.8% | Beat |
| 12 May 2022 16:00 | -0.20 | -0.28 | -42.5% | Miss |
| 17 Mar 2022 07:00 | -0.13 | -0.23 | -81.6% | Miss |
| 03 Nov 2021 16:00 | -0.15 | -0.14 | +6.7% | Beat |
| 10 Aug 2021 16:00 | -0.16 | -0.13 | +18.8% | Beat |
| 13 May 2021 07:00 | -0.27 | -0.21 | +22.2% | Beat |
| 22 Mar 2021 23:00 | -0.36 | -0.38 | -5.6% | Miss |
| 06 Nov 2020 16:00 | -0.36 | -0.40 | -11.1% | Miss |
| 10 Aug 2020 07:00 | -0.48 | -0.49 | -2.1% | Miss |
| 11 May 2020 16:00 | -0.55 | -0.52 | +5.5% | Beat |
| 11 Mar 2020 07:00 | -0.72 | -0.72 | 0.0% | In line |
| 13 Nov 2019 17:00 | -0.72 | -0.72 | 0.0% | In line |
| 08 Aug 2019 07:00 | -0.72 | -0.31 | +57.2% | Beat |
| 02 May 2019 10:00 | -0.58 | -0.87 | -50.0% | Miss |
| 26 Feb 2019 07:00 | -0.61 | -0.63 | -1.8% | Miss |
| 31 Oct 2018 07:00 | -0.58 | -0.62 | -7.8% | Miss |
Annual results · USD
| Year | Revenue | Change | Net income | Net margin | EPS | EPS change | Free cash flow |
|---|---|---|---|---|---|---|---|
| 2025 | 158.3M | +1,031.2% | -68.9M | -43.5% | -0.80 | +51.8% | -42M |
| 2024 | 14M | -20.0% | -128.3M | -916.6% | -1.66 | -37.2% | -101.9M |
| 2023 | 17.5M | +9.7% | -78.5M | -448.9% | -1.21 | -80.6% | -52.9M |
| 2022 | 15.9M | — | -41M | -257.4% | -0.67 | — | -29.2M |
Dates and earnings per share from the company reports as collected by the data provider; the estimate is the analysts' average before the report. Information, not advice.
Prices by day, week and month
| Period | Opening price | High | Low | Closing price | Change | Volume | Dividend |
|---|---|---|---|---|---|---|---|
| 02 Mar 2023 | 7.32 | 7.43 | 7.17 | 7.18 | -3.36% | 414,700 | |
| 01 Mar 2023 | 7.58 | 7.64 | 7.40 | 7.43 | -1.85% | 274,300 | |
| 28 Feb 2023 | 7.58 | 7.79 | 7.51 | 7.57 | +0.13% | 239,300 | |
| 27 Feb 2023 | 7.52 | 7.62 | 7.42 | 7.56 | +1.07% | 241,300 | |
| 24 Feb 2023 | 7.59 | 7.63 | 7.38 | 7.48 | -1.97% | 305,800 | |
| 23 Feb 2023 | 7.50 | 7.77 | 7.33 | 7.63 | +2.01% | 334,700 | |
| 22 Feb 2023 | 7.42 | 7.54 | 7.37 | 7.48 | +0.40% | 336,200 | |
| 21 Feb 2023 | 7.73 | 7.83 | 7.33 | 7.45 | -4.85% | 438,900 | |
| 17 Feb 2023 | 7.85 | 7.92 | 7.59 | 7.83 | -1.01% | 615,600 | |
| 16 Feb 2023 | 7.08 | 8.10 | 7.08 | 7.91 | +12.52% | 1,342,600 | |
| 15 Feb 2023 | 6.91 | 7.08 | 6.87 | 7.03 | +1.01% | 275,100 | |
| 14 Feb 2023 | 6.86 | 7.02 | 6.77 | 6.96 | +0.43% | 263,800 | |
| 13 Feb 2023 | 6.86 | 6.97 | 6.81 | 6.93 | +0.87% | 166,100 | |
| 10 Feb 2023 | 6.80 | 6.97 | 6.72 | 6.87 | +0.44% | 405,000 | |
| 09 Feb 2023 | 6.91 | 6.98 | 6.79 | 6.84 | -0.29% | 273,000 | |
| 08 Feb 2023 | 6.97 | 7.04 | 6.81 | 6.86 | -1.58% | 313,400 | |
| 07 Feb 2023 | 6.70 | 7.00 | 6.69 | 6.97 | +1.01% | 415,300 | |
| 06 Feb 2023 | 7.12 | 7.18 | 6.76 | 6.90 | -3.23% | 614,500 | |
| 03 Feb 2023 | 7.13 | 7.37 | 7.06 | 7.13 | +1.71% | 625,200 | |
| 02 Feb 2023 | 6.40 | 7.20 | 6.31 | 7.01 | +9.70% | 1,729,700 | |
| 01 Feb 2023 | 6.59 | 6.60 | 6.29 | 6.39 | -3.18% | 481,800 | |
| 31 Jan 2023 | 6.30 | 6.61 | 6.30 | 6.60 | +4.93% | 348,900 | |
| 30 Jan 2023 | 6.60 | 6.68 | 6.21 | 6.29 | -5.84% | 503,500 | |
| 27 Jan 2023 | 6.76 | 6.89 | 6.51 | 6.68 | -1.18% | 586,600 | |
| 26 Jan 2023 | 6.94 | 7.05 | 6.64 | 6.76 | -2.59% | 414,900 |
Page 38 of 51
Prices in USD, adjusted for splits but not for dividends. Weeks run Monday to Friday and months follow the calendar; the change compares each close with the previous period's. Dividends are those whose ex-dividend date falls in the period, per share. Information, not advice.
News
- Liquidia Corp (NASDAQ:LQDA) Offers Affordable Growth With Strong Revenue and Reasonable Forward Valuation (opens in a new tab) ChartMill · 04 Nov 2026 10:31
- Liquidia Corporation to Report Third Quarter 2026 Financial Results on November 10, 2026 (opens in a new tab) 03 Nov 2026 13:30
- What Is Behind Liquidia's Lead Over Its Industry? (opens in a new tab) Trefis · 29 Oct 2026 18:42
- Liquidia Gears Up to Report Q3 Earnings: What Can Investors Expect? (opens in a new tab) Zacks · 28 Oct 2026 14:50
- Liquidia Corporation (LQDA) Earnings Expected to Grow: Should You Buy? (opens in a new tab) Zacks · 26 Oct 2026 13:00
- Can Liquidia (LQDA) Still Justify Its Price After Settlement? (opens in a new tab) Simply Wall St. · 24 Oct 2026 13:08
- United Therapeutics' Tyvaso Outlook Faces Near-Term Pressure After Liquidia Settlement, RBC Says (opens in a new tab) MT Newswires · 22 Oct 2026 16:35
- Stocktwits Wall Street Wrap: Crocs, Liquidia Win Upgrades While SpaceX Competition And Grocery Woes Put AST SpaceMobile, Albertsons Under Pressure (opens in a new tab) Stocktwits · 16 Oct 2026 10:26
- Why Liquidia (LQDA) Is Up 24.1% After Striking Costly Peace Deal On YUTREPIA Litigation (opens in a new tab) Simply Wall St. · 16 Oct 2026 02:12
- How Much Downside Is Left In Liquidia Stock? (opens in a new tab) Trefis · 15 Oct 2026 02:47
- Is United Therapeutics (UTHR) Undervalued After Its Legal Settlement? (opens in a new tab) Simply Wall St. · 15 Oct 2026 02:16
- United Therapeutics (UTHR) Settles Litigation And Resets Pulmonary Hypertension Competition (opens in a new tab) Simply Wall St. · 15 Oct 2026 00:20
- What to Know as Liquidia, United Therapeutics Settlement Sends LQDA Stock Soaring (opens in a new tab) Barchart · 14 Oct 2026 21:41
- LQDA Settles UTHR Disputes for $380.7M, Limits Yutrepia Label (opens in a new tab) Zacks · 14 Oct 2026 17:38
- Liquidia shares surge 25% as settlement ends United Therapeutics litigation (opens in a new tab) Proactive · 14 Oct 2026 17:07
Headlines link to the original articles of the publishers shown; NowoTrade does not write, check or endorse them. Only the most relevant news about each company is kept. Information, not advice.
Key data
- Previous close
- 44.49 USD
- Market cap
- 4.0B
- Exchange
- NasdaqCM
- Country
- United States
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Currency
- USD
Dividends
No dividends on record.
Why this score
| Part of the score | Points | Why |
|---|---|---|
| Business growth Yearly growth of revenue and of earnings per share. | 25.0 / 25 |
|
| Quality Return on equity, net margin and how stable the margins are. | 16.7 / 25 |
|
| Financial strength Net debt against operating earnings, interest cover and free cash flow. | 12.1 / 20 |
|
| Valuation Free cash flow yield and the P/E against its sector. | 7.0 / 15 |
|
| Analysts How far the analysts' average target is from today's price. | 10.0 / 10 |
|
- Score capped at 50: three or more warnings
- Thin interest cover: operating profit is only -2.1× the interest
- The last full year was a loss
- Total debt has risen three years in a row
Growth profile: it pays no dividend, so it is scored on business growth, quality and financial strength. Based on 95% of the figures (grade A). Warnings take 18 points off.
Warnings take points off and some cap the score. In your account the score also considers how the share fits your portfolio.
Figures
| Figure | Value | Reading | Sector median |
|---|---|---|---|
| P/E (trailing) | 31.94× | Weak | 30.65× |
| P/E (forward) | 20.3× | Fair | 14.89× |
| Price / book | 20.27× | Weak | 3.8× |
| Price / sales | 8.81× | Weak | 3.19× |
| EV / EBITDA | 22.81× | Weak | 12.61× |
| Free cash flow yield | 1.9% | Weak | 2.5% |
| Figure | Value | Reading | Sector median |
|---|---|---|---|
| Gross margin | 92.5% | Good | 58.6% |
| Operating margin | 49.8% | Good | 7.6% |
| Net margin | 30.7% | Good | 2.7% |
| Return on equity | 131.8% | Good | 5.7% |
| Return on assets | 27% | Good | 3.5% |
| Figure | Value | Reading | Sector median |
|---|---|---|---|
| Revenue growth / year | 115% | Good | 10.8% |
| Figure | Value | Reading | Sector median |
|---|---|---|---|
| Debt / equity | 0.94× | Fair | 0.48× |
| Net debt / EBITDA | -0.6× | Good | 1.6× |
| Interest cover | -2.13× | Weak | 2.65× |
| Current ratio | 2.31× | Good | 2.36× |
| Figure | Value | Reading | Sector median |
|---|---|---|---|
| Payout of earnings | 0% | Weak | 0% |
The reading follows general rules of thumb and each sector has its own norms: compare with the sector median when it is shown. Information, not advice.
Follow LQDA and get alerts
Create a free account to add it to your watchlist, set a price alert, see how it fits your portfolio and track your dividends.